UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058840
Receipt number R000067284
Scientific Title Verification research on the effects of test foods on intestinal flora
Date of disclosure of the study information 2025/08/19
Last modified on 2025/08/19 16:13:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Verification research on the effects of test foods on intestinal flora

Acronym

Verification research on the effects of test foods on intestinal flora

Scientific Title

Verification research on the effects of test foods on intestinal flora

Scientific Title:Acronym

Verification research on the effects of test foods on intestinal flora

Region

Japan


Condition

Condition

Healthy Adults

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Investigate the effects of ingestion of kestose and inulin-containing oligosaccharide syrup containing honey on the intestinal environment of healthy adults and to clarify its effectiveness.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Fecal bacterial flora

Key secondary outcomes

Questionnaire


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Intake 15 g of oligosaccharide syrup with honey every day for 4 weeks.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

1. Persons who are aged 18 to 75 at the time of consent, both men and women
2. Persons who are not suffering from intestinal diseases (including those who are judged not to require immediate treatment)
3. Persons who received a sufficient explanation of the purpose and contents of the research, have the capacity to consent

Key exclusion criteria

1. Persons who may experience abdominal pain when eating materials containing honey and oligosaccharides such as kestose
2. Persons who have been diagnosed with a digestive disease, previously undergone digestive surgery, and will require digestive surgery in the future
3. Persons who regularly use materials containing honey or oligosaccharides such as kestose (at least 3 days a week) or have regularly used such materials within the 3 months prior to the pre-test
4. Persons who have been diagnosed with malignant tumors, currently receiving treatment for cranial nerve, heart, kidney, diabetes, or thyroid dysfunction, and with a history of serious illnesses such as liver disease, excluding illnesses like hypertension, which principal investigator determined will not affect the evaluation of the research.
5. Persons who drink a large amount of alcohol (60 g or more of alcohol per day: approximately 1500 mL of beer, 540 mL of wine, 3 cups of sake, or 180 mL of double-sized whiskey)
6. Persons who are at risk of developing allergies related to the test foods
7. Persons who are judged unsuitable as research subjects based on their responses to a background survey
8. Persons who have participated in other research during one month prior to the start of this research, or plan to participate in other research after consenting to this research.
9. Persons who are judged to be ineligible by the principal investigator

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Kenshiro
Middle name
Last name Ikeda

Organization

VOREAS, INC.

Division name

CEO

Zip code

070-0842

Address

HOKUO LAB 2F, 21-482 Omachi 2-jo 6-chome, Asahikawa City, Hokkaido, Japan

TEL

0166-57-8228

Email

ken-ikeda@voreas.jp


Public contact

Name of contact person

1st name Takumi
Middle name
Last name Tochio

Organization

BIOSIS Lab. Co., Ltd.

Division name

CEO

Zip code

470-1101

Address

Room 506, Building No. 11, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, JAPAN

TEL

090-6904-6772

Homepage URL


Email

takumitochiobiz@gmail.com


Sponsor or person

Institute

VOREAS, INC.

Institute

Department

Personal name



Funding Source

Organization

VOREAS, INC.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committee

Address

1-18-26-204 Miharadai, Nerima-ku, Tokyo

Tel

080-7385-7987

Email

info@okutoeru.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 08 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

20

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2025 Year 03 Month 01 Day

Date of IRB

2025 Year 03 Month 01 Day

Anticipated trial start date

2025 Year 03 Month 02 Day

Last follow-up date

2025 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 08 Month 19 Day

Last modified on

2025 Year 08 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067284